DR. BELA AJTAI MD PHD NPI 1316155500

NPI Information

  • NPI: 1316155500
  • Provider Name: DR. BELA AJTAI, MD, PHD
  • Classification: Psychiatry & Neurology - 2084N0400X
  • Specialization: Neurology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3980A SHERIDAN DR
    AMHERST, NY
    ZIP 14226
  • Phone: (716) 250-2000

Map and Directions

Get Directions

NPI Details

DR. Bela Ajtai, MD, PHD is a neurology psychiatry neurology in Amherst, NY with 28 years of experience. The provider is a Neurologist specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures. DR. Bela Ajtai, MD, PHD NPI is 1316155500. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3980A SHERIDAN DR
AMHERST, NY
ZIP 14226-727
Phone: (716) 250-2000
Fax: (716) 250-2040

The NPI 1316155500 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
  • Injection, vedolizumab, 1 mg (HCPCS:J3380)
  • Injection, ocrelizumab, 1 mg (HCPCS:J2350)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, eptinezumab-jjmr, 1 mg (HCPCS:J3032)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, gadobenate dimeglumine (multihance multipack), per ml (HCPCS:A9578)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Assessment of and care planning for impaired thought processing, typically 50 minutes (HCPCS:99483)
  • Mri scan of brain without contrast (HCPCS:70551)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Mri scan of brain before and after contrast (HCPCS:70553)
  • 3d radiographic procedure with computerized image postprocessing (HCPCS:76377)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Ct scan head or brain without contrast (HCPCS:70450)
  • Mri scan of blood vessels of head before and after contrast (HCPCS:70546)
  • Mri scan of blood vessels of head without contrast (HCPCS:70544)
  • Mri scan of upper spinal canal without contrast (HCPCS:72141)
  • 3d radiographic procedure (HCPCS:76376)
  • Mri scan of lower spinal canal without contrast (HCPCS:72148)
  • Unclassified drugs (HCPCS:J3490)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Mri scan of blood vessels of neck before and after contrast (HCPCS:70549)
  • Mri scan of upper spinal canal before and after contrast (HCPCS:72156)

The enumeration date for this NPI number is 5/19/2007 and was last updated on 2/14/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
12084N0400XPsychiatry & NeurologyNeurology002751NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.